supported by grants received from CAAST-ACLH(NAHEP/CAAST/2018-19);ICAR-World Bank-funded National Agricultural Higher Education Project(NAHEP).
Background:Vancomycin resistance(VR)in staphylococci is emerging fast and posing serious health problems as vancomycin is considered the drug of choice for the treatment of methicillin-resistant staphylococcal infecti...
supported by postdoctoral fellowship,Thammasat University(Rangsit Campus),Thailand;Kesara Na-Bangchang was received funding from Thammasat University under the project Center of Excellence in Pharmacology and Molecular Biology of Malaria and Cholangiocarcinoma(No.1/2556,dated October 12,2013);the National Research Council of Thailand(No.45/2561,dated September 10,2018);Kesara Na-Bangchang is supported by the National Research Council of Thailand under the Research Team Promotion grant(grant number NRCT 820/2563,dated November 12,2020).
Background:Secondary antimicrobial resistance bacterial(AMR)pneumonia could lead to an increase in mortality in COVID-19 patients,particularly of geriatric patients with underlying diseases.The comedication of current...
Staphylococcus aureus is major human pathogen causing large variety of infections worldwide. This study carried out to isolate S. aureus from different clinical cases, also detection of MRSA prevalence and VRSA emerge...
Multidrug resistant Staphylococcus aureus (MDRS) is a serious threat to hospitalized patients globally and now represents a challenge for public health, as community-acquired infections appear to be on the increase in...